The American,6 British7 and European2 liver societies have issued guidelines recommending HCC surveillance every 6 months, with patients reviewed by a healthcare professional (HCP) with imaging (ultrasonography) and blood tests including alpha-fetoprotein (AFP) to ensure that early HCC lesions are detected and treated. Here, AFP is linked to hepatocellular carcinoma.